SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001829126-21-011863
Filing Date
2021-10-12
Accepted
2021-10-12 13:32:15
Documents
12
Period of Report
2021-10-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K/A inspyrtherapeutics_8ka.htm   iXBRL 8-K/A 24301
  Complete submission text file 0001829126-21-011863.txt   193244

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nspxd-20211012.xsd EX-101.SCH 3028
3 XBRL LABEL FILE nspxd-20211012_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE nspxd-20211012_pre.xml EX-101.PRE 22360
5 EXTRACTED XBRL INSTANCE DOCUMENT inspyrtherapeutics_8ka_htm.xml XML 3836
Mailing Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361
Business Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-55331 | Film No.: 211318191
SIC: 2834 Pharmaceutical Preparations